Jackton Indangasi

Keppel Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.

Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.

Journal: Vaccine

Published: January 24, 2026

Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial.

Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial.

Journal: NPJ vaccines

Published: July 15, 2025

Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial.

Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial.

Journal: NPJ vaccines

Published: June 16, 2025

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.

Journal: The Lancet. Global health

Published: April 21, 2024

Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.

Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.

Journal: The Lancet. Global health

Published: August 09, 2023

Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.

Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.

Journal: The Lancet. Global health

Published: February 20, 2022

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.

Journal: The Lancet. Global health

Published: February 20, 2022

Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.

Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.

Journal: African journal of laboratory medicine

Published: June 06, 2019

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.

Journal: Molecular therapy. Methods & clinical development

Published: July 21, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026